Qubit Pharmaceuticals and Sorbonne University achieve a major scientific breakthrough by simulating quantum calculations at more than 40 qubits on conventional computers
Qubit Pharmaceuticals introduces its Hyperion-1 emulator, developed in close collaboration with Sorbonne University and capable of running accelerated and accurate quantum algorithms at over 40 qubits.
- Qubit Pharmaceuticals introduces its Hyperion-1 emulator, developed in close collaboration with Sorbonne University and capable of running accelerated and accurate quantum algorithms at over 40 qubits.
- Paris, December 6th, 2023 - Qubit Pharmaceuticals, a deeptech company specializing in the discovery of new drug candidates through molecular simulation and modeling accelerated by hybrid HPC and quantum computing, announces a major scientific breakthrough after achieving quantum computations simulating 40 qubits with its new Hyperion-1 emulator.
- This achievement reinforces Qubit Pharmaceuticals' ambition to become the industry reference in molecular modeling-based drug discovery.
- Exceptional performance: Hyperion-1 has demonstrated outstanding performance in high-speed simulations of complex quantum circuits of up to 40 qubits, using moderate computing resources, i.e.